Amit Kumar

Employment

• Monash Health Lead Clinical Bioinformatician
  2021 - Present
• Peter MacCallum Cancer Centre Clinical Cancer Bioinformatics Post-doc
  2015 - 2023

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Cellular myofibromas with SRF fusions: Clinicopathological and molecular study of three cases of a rare entity and a potential mimic of sarcoma
  Human Pathology 2023 DOI: 10.1016/j.humpath.2023.05.012
  +Save
• Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions
  2022 DOI: 10.21203/rs.3.rs-1714034/v1
  +Save
• In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
  EMBO Molecular Medicine 2022 DOI: 10.15252/emmm.202114608
  +Save
• Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
  2020 DOI: 10.1101/2020.11.18.389312
  +Save
• Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
  Nature Medicine 2020 DOI: 10.1038/s41591-020-1072-4
  +Save
• Comparative analysis of milk microRNA in the therian lineage highlights the evolution of lactation.
  Reproduction, fertility, and development 2019 DOI: 10.1071/rd18199
  +Save
• CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencing.
  Scientific reports 2019 DOI: 10.1038/s41598-019-42858-8
  +Save
• Overview of Fusion Detection Strategies Using Next-Generation Sequencing.
  Methods in molecular biology (Clifton, N.J.) 2019 DOI: 10.1007/978-1-4939-9004-7_9
  +Save
• Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.
  Cancer biology & therapy 2018 DOI: 10.1080/15384047.2018.1491498
  +Save
• Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
  British journal of cancer 2018 DOI: 10.1038/s41416-018-0251-2
  +Save